We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Adds Immediate-Release Opioids to REMS to Expand Training, Labeling
FDA Adds Immediate-Release Opioids to REMS to Expand Training, Labeling
The FDA Tuesday added immediate-release opioids to its risk evaluation and mitigation strategy (REMS) for opioid analgesics, saying the move will encourage “rational prescribing.”